Intraoperative Radiation Therapy Market to Register Stunning CAGR of 6.4% by 2025

2022-05-11 05:19:59 UTC | Healthcare & Pharmaceuticals
Intraoperative Radiation Therapy Market to Register Stunning CAGR of 6.4% by 2025

The technological advancements such as the introduction of mobile IORT system,  rising incidence of cancer, and advantages offered by IORT over conventional radiotherapy are the major factors driving the growth of the global intraoperative radiation therapy market. Additionally, growing clinical trials exploring the use of IORT for various cancer applications is expected to offer lucrative growth opportunities to market players. 


Global intraoperative radiation therapy market is projected to reach USD 66 million by 2025 from USD 48 million in 2020, at a CAGR of 6.4% during the forecast period. 


Access Sample Copy of the Report @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=245000083 


Intraoperative radiation therapy market Dynamics 


Driver: Growing global prevalence of cancer 

The IORT procedure is associated with various advantages such as targeted radiation, limited treatment time, high precision and radiation control, and minimal radiation exposure of normal tissue. This is especially true for breast cancer, as this mode offers women a choice of breast-sparing treatment (lumpectomy). The increasing prevalence of breast cancer is, therefore, a key factor driving the market growth. The growing prevalence of cancer will increase the adoption of IORT procedures. Some key statistics in this regard have been mentioned below: 

  • In 2020, 276,480 new cases of invasive breast cancer and 48,530 new cases of non-invasive breast cancer were reported in the US (Source: Breastcancer.org). 

  • In 2018, around 17.0 million new cases of cancer were reported worldwide; this figure is expected to reach 27.5 million by 2040 (Source: International Agency for Research on Cancer). 

  • According to the American Cancer Society, in 2018, around 1.8 million new cases of cancer were diagnosed in the US. 


Restraint: Dearth of trained personnel 

A high level of accuracy is needed at every step of the process to achieve maximum tumor control and ensure minimal risk to normal tissue. Procedural errors can occur due to interconnectivity issues between different treatment planning and delivery and monitoring systems, thus increasing risks for patients. These complexities associated with IORT pose a challenge towards its widespread adoption in cancer treatment. 


Opportunity: Growing applications of IORT 

Over the years, IORT has found significant applications as a breast-conserving treatment. Technological advancements in this field, coupled with the growing applications of IORT, has resulted in the increasing collaboration between a large number of manufacturers and research institutes to conduct clinical trials to study the applications and efficacy of IORT for other cancer types. The primary aim of these clinical trials is to analyze and evaluate the feasibility of IORT treatment across various cancer applications. Some of the recent trials and projects include: 


  • In 2019, IntraOp Medical, Inc. (US), in collaboration with the Massachusetts General Hospital, initiated a study to investigate the effectivity of electron beam intraoperative radiation therapy following chemoradiation in patients with pancreatic cancer. 

  • In 2018, A.C. Camargo Cancer Center collaborated with Carl Zeiss Meditec AG (Germany) to sponsor the “Focal Intraoperative Radiotherapy after Resection of Brain Metastases” trial. 


Challenge: Risk of radiation exposure 

The high radiation doses involved with therapeutic exposures have the potential to cause harm to not only the patients opting for treatment but also to the healthcare staff and people in the surrounding areas in case there is involuntary radiation exposure. This may result in various side-effects, such as vomiting, diarrhea, and nausea. 


North America to dominate the intraoperative radiation therapy market during the forecast period 

The intraoperative radiation therapy market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The North American region is expected to account for the largest share of the intraoperative radiation therapy market in 2019. The growth in this market is mainly attributed to the increasing healthcare expenditure in the region, technological advancements, and high adoption of IORT products owing to the increasing incidence of cancer. 


The major players operating in the intraoperative radiation therapy market are ZEISS Group (Germany), iCAD, Inc. (US), Eckert & Ziegler (Germany), Elekta AB (Sweden), GMV Innovating Solutions (Spain), Sensus Healthcare, Inc. (US), IntraOp Medical, Inc. (US), Isoray, Inc. (US), Becton, Dickinson and Company (US), Sordina IORT Technologies (Italy), Varian Medical Systems, Inc. (US), SeeDos Ltd. (UK), IsoAid LLC (US), Ariane Medical Systems Ltd. (UK), Panacea Medical Technologies Pvt. Ltd. (India), Salutaris Medical Devices (US), Brainlab AG (Germany), RaySearch Laboratories (Sweden), REMEDI Co., Ltd. (South Korea), Merit Medical Systems, Inc. (US), among others. 


Don’t miss out on business opportunities in Intraoperative Radiation Therapy Market. Speak to our analyst and gain crucial industry insights that will help your business grow. 



About MarketsandMarkets 

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. 


Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve. 


MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. 


Contact: 
Mr. Aashish Mehra 
MarketsandMarkets™ INC. 
630 Dundee Road 
Suite 430 
Northbrook, IL 60062 
USA : 1-888-600-6441 
sales@marketsandmarkets.com 

Top